Home › Funds › Moore Capital Management › BIO
Moore Capital Management position in BIO
BIO RAD LABS INC · Industrials
Latest position (Q4 2025)50.00K sh
Reported value held$15.15M
Portfolio Weight0.22%
First reportedQ1 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 1.10K | $526.92K | New |
| Q2 2023 | 25.00K | $9.48M | Add |
| Q3 2023 | 12.50K | $4.48M | Reduce |
| Q3 2024 | 45.00K | $15.06M | New |
| Q4 2024 | 45.00K | $14.78M | Hold |
| Q1 2025 | 10.00K | $2.44M | Reduce |
| Q3 2025 | 55.00K | $15.42M | New |
| Q4 2025 | 50.00K | $15.15M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BIO
- First Eagle Investment Management 2.61M sh · $765.21M · Q2 2026
- Vanguard Group 1.77M sh · $537.58M · Q4 2025
- BlackRock Inc 1.70M sh · $498.82M · Q2 2026
- Bank of America Corp 490.41K sh · $143.99M · Q2 2026
- Capital World Investors 462.46K sh · $135.78M · Q2 2026
- Capital Research Global Investors 443.48K sh · $130.21M · Q2 2026
- Geode Capital Management 347.57K sh · $102.08M · Q2 2026
- UBS Group AG 308.32K sh · $90.53M · Q2 2026
- Northern Trust Corp 218.28K sh · $64.09M · Q2 2026
- Charles Schwab Investment Management 195.54K sh · $57.41M · Q2 2026
- Franklin Resources 193.68K sh · $56.87M · Q2 2026
- AQR Capital Management 192.71K sh · $56.05M · Q2 2026